GENE BRIDGES GMBH has a total of 42 patent applications. It decreased the IP activity by 100.0%. Its first patent ever was published in 2001. It filed its patents most often in United Kingdom, EPO (European Patent Office) and WIPO (World Intellectual Property Organization). Its main competitors in its focus markets biotechnology, pharmaceuticals and organic fine chemistry are CELLTHEON CORP, TransAlgae Ltd and BODIE ELIZABETH A.
# | Country | Total Patents | |
---|---|---|---|
#1 | United Kingdom | 11 | |
#2 | EPO (European Patent Office) | 7 | |
#3 | WIPO (World Intellectual Property Organization) | 7 | |
#4 | China | 5 | |
#5 | Canada | 4 | |
#6 | Australia | 3 | |
#7 | United States | 3 | |
#8 | Japan | 1 | |
#9 | Singapore | 1 |
# | Industry | |
---|---|---|
#1 | Biotechnology | |
#2 | Pharmaceuticals | |
#3 | Organic fine chemistry | |
#4 | Foods and drinks | |
#5 | Environmental technology |
# | Technology | |
---|---|---|
#1 | Microorganisms | |
#2 | Fermentation | |
#3 | Peptides | |
#4 | Therapeutic chemical compounds | |
#5 | Climate change mitigation in goods production | |
#6 | Enzymes | |
#7 | Heterocyclic compounds | |
#8 | Compounds of unknown constitution | |
#9 | Medical preparations |
# | Name | Total Patents |
---|---|---|
#1 | Zhang Youming | 27 |
#2 | Fu Jun | 25 |
#3 | Stewart Adrian Francis | 15 |
#4 | Stewart Francis | 14 |
#5 | Mueller Rolf | 5 |
#6 | Maresca Marcello | 5 |
#7 | Seibert Philipp Martin | 4 |
#8 | Ehrhardt Anja | 4 |
#9 | Erler Axel Steffen | 4 |
#10 | Muijrers Joep P P | 4 |
Publication | Filing date | Title |
---|---|---|
CN109715813A | Adenovirus vector | |
GB201506192D0 | Electrocompetent cells and preparation thereof | |
GB201011131D0 | Heterologous hosts | |
GB201009732D0 | Direct cloning | |
GB0922108D0 | Heterologous hosts | |
WO2010049807A2 | T7 dual promoter-based vector system for recombinant expression of polypeptides | |
GB0909660D0 | Method of altering nucleic acids | |
GB0905458D0 | Method of altering nucleic acids | |
AU2008202476A1 | Recombination method | |
GB0803109D0 | Method of nucleic acid recombination | |
GB0707315D0 | Novel proteasome inhibitor | |
GB0423755D0 | Methods for heterologus expression of secondary metabolites | |
WO02062988A2 | Recombination method | |
GB0120312D0 | Recombination method | |
GB0103276D0 | Recombination method |